VISTAS 2023 - Drive the Momentum - October 18-20, Caesars Palace, Las Vegas - Learn More

The Pharma Inflation Reduction Act (IRA) Storm: Will You Sink Or Swim?

Drowning in a sea of provisions and policies?  

pharma inflation reduction act IRA

On June 30, 2023, the Centers for Medicare & Medicaid Services (CMS) released its updated final program guidance covering the Inflation Reduction Act Medicare Price Negotiation Program for the first round of negotiations. This round covers 2023 and 2024 and will make prices effective starting in 2026.

Even if your company’s drug isn’t among the first 10 selected, it’s better to be proactive than reactive. Helping you navigate the many moving parts, our Life Sciences team of experts regularly tracks and closely connects with trends developing in the industry.  

Download our Inflation Reduction Act Data Placemat to reference the complex components and better plan. Pass it around…and check back for updates.

If your pharma company isn’t already floating around ideas for a compliant approach to the IRA, you will end up in reactive mode soon, substantially impacting your revenue. Watch for our upcoming eBook: A Compliant Approach to IRA, outlining the pitfalls and pain points you will likely encounter and ways Vistex can solve for them.